Iotalamic acid | Iothalamic acid | AmBeed-信号通路专用抑制剂

首页 / Iotalamic acid/碘他拉酸

Iotalamic acid/碘他拉酸 {[allProObj[0].p_purity_real_show]}

货号：A685161 同义名： Iothalamic acid

Lotalamic acid is a molecule used as a contrast medium.

Iotalamic acid/碘他拉酸化学结构
CAS号：2276-90-6

Iotalamic acid/碘他拉酸 3D分子结构
CAS号：2276-90-6

规格	价格	会员价	库存	数量
{[ item.pr_size ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]}	{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]}	现货	1周咨询	- +

购物车0 收藏询单

sales@ambeed.cn tech@ambeed.cn 400-920-2911 产品手册产品订购技术咨询
快速发货顺丰冷链运输，1-2 天到达

品质保证

技术支持

免费溶解

Iotalamic acid/碘他拉酸纯度/质量文件产品仅供科研

货号：A685161 标准纯度： {[allProObj[0].p_purity_real_show]} 产品说明书

批次查询：批次纯度: COA SDS NMR HPLC CNMR LC-MS

全球学术期刊中引用的产品: • Adv. Funct. Mater., 2025, 2500696. Ambeed. [ A245395 ]; • JACS, 2025. Ambeed. [ A505336 ]; • Sci. Adv., 2025, 11(13): eadr0006. Ambeed. [ A152627 ]; • ACS Appl. Mater. Interfaces, 2025, 17(12): 18046-18058. Ambeed. [ A739356 , A171817 ]; • Food Res. Int., 2025, 116191. Ambeed. [ A1452012 ]; 更多 >

Iotalamic acid/碘他拉酸生物活性

描述	Lotalamic acid is a molecule used as a contrast medium.

Iotalamic acid/碘他拉酸临床研究

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点
NCT00555321	Immunosuppression in Solid Org... 展开 >>an Transplant 收起 <<	Phase 2	Terminated	-	-
NCT03168906	Amyloidosis	Phase 2	Active, not recruiting	July 2019	United States, Arizona ... 展开 >> Mayo Clinic- Arizona Scottsdale, Arizona, United States, 85259 United States, California University of California San Francisco San Francisco, California, United States, 94143 United States, Florida Mayo Clinic- Florida Jacksonville, Florida, United States, 32224 United States, Massachusetts Tufts Medical Center Boston, Massachusetts, United States, 02111 United States, Michigan Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Minnesota Mayo Clinic- Minnesota Rochester, Minnesota, United States, 55905 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Pennsylvania Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 收起 <<
NCT00214786	-		Completed	-	-

Iotalamic acid/碘他拉酸参考文献

[1]Shah I, Barker J, et al. HPLC estimation of iothalamate to measure glomerular filtration rate in humans. Chem Cent J. 2016 Dec 12;10:80.

Iotalamic acid/碘他拉酸实验方案

计算器

存储液制备

1mg

5mg

10mg

1 mM

5 mM

10 mM

1.63mL

0.33mL

0.16mL

8.14mL

1.63mL

0.81mL

16.29mL

3.26mL

1.63mL

Iotalamic acid/碘他拉酸技术信息

CAS号	2276-90-6
分子式	C₁₁H₉I₃N₂O₄
分子量	613.91
SMILES Code	O=C(O)C1=C(I)C(C(NC)=O)=C(I)C(NC(C)=O)=C1I
MDL No.	MFCD00800738

别名	Iothalamic acid
运输	蓝冰
InChI Key	UXIGWFXRQKWHHA-UHFFFAOYSA-N
Pubchem ID	3737

存储条件

In solvent -20°C:3-6个月-80°C:12个月

Pure form Keep in dark place, sealed in dry, room temperature

溶解方案

细胞实验：

DMSO: 25 mg/mL(40.72 mM)，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO

动物实验：请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液，再依次添加助溶剂：
——为保证实验结果的可靠性，澄清的储备液可以根据储存条件，适当保存；体内实验的工作液，建议现用现配，当天使用；以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比；如在配制过程中出现沉淀、析出现象，可以通过加热和/或超声的方式助溶

方案一

方案二

临床研究

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点

NCT00555321	Immunosuppression in Solid Org... 展开 >>an Transplant 收起 <<	Phase 2	Terminated	-	-
NCT03168906	Amyloidosis	Phase 2	Active, not recruiting	July 2019	United States, Arizona ... 展开 >> Mayo Clinic- Arizona Scottsdale, Arizona, United States, 85259 United States, California University of California San Francisco San Francisco, California, United States, 94143 United States, Florida Mayo Clinic- Florida Jacksonville, Florida, United States, 32224 United States, Massachusetts Tufts Medical Center Boston, Massachusetts, United States, 02111 United States, Michigan Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Minnesota Mayo Clinic- Minnesota Rochester, Minnesota, United States, 55905 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Pennsylvania Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 收起 <<
NCT00214786	-		Completed	-	-
NCT00214786	Type 1 Diabetes	Phase 1	Completed	-	United States, Texas ... 展开 >> Baylor Regional Transplant Institute - Baylor University Medical Center Dallas, Texas, United States, 75246 收起 <<
NCT00252187	Congestive Heart Failure ... 展开 >> Cardiomyopathy 收起 <<	Phase 1 Phase 2	Completed	-	United States, Minnesota ... 展开 >> Mayo Clinic Rochester, Minnesota, United States, 55905 收起 <<
NCT00555321	-		Terminated	-	-
NCT00346151	-		Terminated(Stopping rule-acute... 展开 >> rejection threshold-was met based on local biopsy results) 收起 <<	-	-
NCT01846468	Chronic Renal Insufficiency	Phase 1	Completed	-	United States, Florida ... 展开 >> Novartis Investigative Site Orlando, Florida, United States, 32809 United States, Tennessee Novartis Investigative Site Knoxville, Tennessee, United States, 37920 收起 <<
NCT01011205	Liver Transplantation	Phase 3	Completed	-	-
NCT00252187	-		Completed	-	-
NCT01302899	Non-diabetic Nephropathy	Phase 2	Terminated(In consequence of t... 展开 >>ermination of ALTITUDE. A number of studies were continued in consultation with the Altitude Data Monitoring Committee.) 收起 <<	-	Netherlands ... 展开 >> Novartis Investigative Site Groningen, Netherlands Novartis Investigative Site Leeuwarden, Netherlands 收起 <<
NCT00346151	Renal Transplant	Phase 2	Terminated(Stopping rule-acute... 展开 >> rejection threshold-was met based on local biopsy results) 收起 <<	-	United States, California ... 展开 >> University of California, San Francisco San Francisco, California, United States, 94143 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 收起 <<
NCT01302899	-		Terminated(In consequence of t... 展开 >>ermination of ALTITUDE. A number of studies were continued in consultation with the Altitude Data Monitoring Committee.) 收起 <<	-	-
NCT00270634	Kidney Diseases	Phase 2	Completed	-	-
NCT03493802	-		Recruiting	November 1, 2020	United States, Minnesota ... 展开 >> Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Kathleen R Leistikow, ACRC 507-266-1316 leistikow.kathleen@mayo.edu Contact: Charles D Madsen, CCRP 507-266-9391 madsen.charles@mayo.edu Principal Investigator: Maria V Irazabal, M.D. 收起 <<
NCT00881439	Heart Failure ... 展开 >> Kidney Failure 收起 <<	Phase 2	Terminated(Futility)	-	Netherlands ... 展开 >> University Medical Center Groningen Groningen, Netherlands 收起 <<
NCT00543569	Kidney Transplantation	Phase 2	Completed	-	-
NCT00617604	-		Completed	-	-
NCT00405548	-		Completed	-	-
NCT00426153	Polycystic Kidney, Autosomal D... 展开 >>ominant Polycystic Liver Disease Hepatomegaly Liver Diseases Kidney, Polycystic Abdominal Pain 收起 <<	Phase 2 Phase 3	Completed	-	United States, Minnesota ... 展开 >> Mayo Clinic Rochester, Minnesota, United States, 55905 收起 <<
NCT00543569	-		Completed	-	-
NCT00270634	-		Completed	-	-
NCT00426153	-		Completed	-	-
NCT00617604	De Novo Kidney Transplantation	Phase 2	Completed	-	-
NCT00166712	Kidney Transplant Failure and ... 展开 >>Rejection 收起 <<	Phase 4	Terminated(Study stopped due t... 展开 >>o lack of efficacy & funding.) 收起 <<	-	United States, Illinois ... 展开 >> Northwestern University/Northwestern Memorial Hospital Chicago, Illinois, United States, 60611 收起 <<
NCT00405548	Left Ventricular Diastolic Dys... 展开 >>function 收起 <<	Phase 1 Phase 2	Completed	-	United States, Minnesota ... 展开 >> Mayo Clinic Rochester, Minnesota, United States, 55905 收起 <<
NCT00587418	Liver Transplant Recipients	Not Applicable	Completed	-	United States, Minnesota ... 展开 >> Mayo Clinic Rochester, Minnesota, United States, 55905 收起 <<
NCT00405639	Heart Failure ... 展开 >> Asymptomatic Systolic Dysfunction 收起 <<	Phase 1 Phase 2	Completed	-	United States, Minnesota ... 展开 >> Mayo Clinic Rochester, Minnesota, United States, 55905 收起 <<
NCT00405639	-		Completed	-	-
NCT01840540	Atherosclerotic Renal Artery S... 展开 >>tenosis Ischemic Nephropathy Renovascular Hypertension 收起 <<	Phase 1	Completed	-	United States, Minnesota ... 展开 >> Mayo Clinic in Rochester Rochester, Minnesota, United States, 55905 收起 <<
NCT00256750	Kidney Transplantation ... 展开 >> Chronic Kidney Failure 收起 <<	Phase 3	Completed	-	-
NCT00982423	-		Completed	-	-
NCT00166712	-		Terminated(Study stopped due t... 展开 >>o lack of efficacy & funding.) 收起 <<	-	-
NCT00348556	Cardiorenal Syndrome	Phase 1 Phase 2	Terminated(Company providing c... 展开 >>atheter bought out, funding and supplies terminated) 收起 <<	-	United States, Minnesota ... 展开 >> Mayo Clinic Rochester, Minnesota, United States, 55905 收起 <<
NCT01936519	Immunosuppression ... 展开 >> Renal Failure 收起 <<	Not Applicable	Active, not recruiting	December 2019	United States, Pennsylvania ... 展开 >> Penn State College of Medicine; Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States, 17033 收起 <<
NCT00348556	-		Terminated(Company providing c... 展开 >>atheter bought out, funding and supplies terminated) 收起 <<	-	-
NCT00982423	Heart Failure ... 展开 >> Kidney Dysfunction 收起 <<	Phase 1 Phase 2	Completed	-	United States, Minnesota ... 展开 >> Mayo Clinic Rochester, Minnesota, United States, 55905 收起 <<
NCT00170846	-		Completed	-	-
NCT00690014	Kidney Disease	Not Applicable	Completed	-	United States, Maryland ... 展开 >> University of Maryland GCRC Baltimore, Maryland, United States, 21201 收起 <<
NCT00170846	Renal Transplantation	Phase 4	Completed	-	Switzerland ... 展开 >> Novartis Basel, Switzerland 收起 <<
NCT00114777	Renal Transplantation	Phase 3	Completed	-	-
NCT01336972	Autosomal Dominant Polycystic ... 展开 >>Kidney Disease 收起 <<	Phase 2	Completed	-	Netherlands ... 展开 >> University Medical Center Groningen Groningen, Netherlands, 9713 GZ 收起 <<
NCT01336972	-		Completed	-	-
NCT00938561	-		Withdrawn(Non availability of ... 展开 >>funding) 收起 <<	-	-
NCT00229684	Diabetes Mellitus, Type 2	Phase 2	Terminated(The development pro... 展开 >>gram has been terminated) 收起 <<	-	United States, California ... 展开 >> Research Site Pasadena, California, United States United States, District of Columbia Research Site Washington, District of Columbia, United States United States, Florida Research Site Gainesville, Florida, United States Research Site Miami, Florida, United States Research Site Orlando, Florida, United States United States, Georgia Research Site Augusta, Georgia, United States Research Site Columbus, Georgia, United States United States, Louisiana Research Site New Orleans, Louisiana, United States United States, Nevada Research Site Reno, Nevada, United States United States, New York Research Site Flushing, New York, United States United States, North Carolina Research Site Durham, North Carolina, United States United States, Ohio Research Site Cleveland, Ohio, United States Research Site Columbus, Ohio, United States United States, Oklahoma Research Site Tulsa, Oklahoma, United States United States, Pennsylvania Research Site Cheswick, Pennsylvania, United States Research Site Philadelphia, Pennsylvania, United States United States, Tennessee Research Site Nashville, Tennessee, United States United States, Texas Research Site Midland, Texas, United States Research Site San Antonio, Texas, United States United States, Washington Research Site Gig Harbor, Washington, United States Research Site Seattle, Washington, United States 收起 <<
NCT00256750	-		Completed	-	-
NCT00114777	-		Completed	-	-
NCT01546532	Chronic Heart Failure (CHF)	Phase 2	Completed	-	United States, Maryland ... 展开 >> Novartis Investigative Site Baltimore, Maryland, United States Germany Novartis Investigative Site Berlin, Germany, 10117 Novartis Investigative Site Erlangen, Germany, 91054 Novartis Investigative Site Goettingen, Germany, 37075 Novartis Investigative Site Hamburg, Germany, 20246 Netherlands Novartis Investigative Site Deventer, Netherlands, 7416 SE Novartis Investigative Site Groningen, Netherlands, 9713 GZ Novartis Investigative Site Sneek, Netherlands, 8601 ZR Poland Novartis Investigative Site Grodzisk Mazowiecki, Poland, 05-825 Novartis Investigative Site Katowice, Poland, 40-637 Novartis Investigative Site Krakow, Poland, 31-202 Novartis Investigative Site Kraków, Poland, 31-501 Novartis Investigative Site Lublin, Poland, 20-954 Novartis Investigative Site Walbrzych, Poland, 58-309 Novartis Investigative Site Warszawa, Poland, 04-628 收起 <<
NCT00121810	Kidney Transplantation	Phase 4	Completed	-	-
NCT01163162	-		Completed	-	-
NCT01163162	Chronic Kidney Disease	Phase 4	Completed	-	United States, Indiana ... 展开 >> Roudebush VA Medical Center Indianapolis, Indiana, United States, 46202 收起 <<
NCT00830037	Chronic Kidney Disease ... 展开 >> Iron-deficiency Anemia 收起 <<	Phase 4	Terminated(Terminated by the D... 展开 >>SMB based on low chance of finding differences in mGFR slopes, but higher risk of serious adverse events in the IV iron group (aIRR = 1.60)) 收起 <<	-	United States, Indiana ... 展开 >> VA Medical Center Indianapolis, Indiana, United States, 46202 收起 <<
NCT00121810	-		Completed	-	-
NCT00830037	-		Terminated(Terminated by the D... 展开 >>SMB based on low chance of finding differences in mGFR slopes, but higher risk of serious adverse events in the IV iron group (aIRR = 1.60)) 收起 <<	-	-
NCT01709136	Hypertension	Phase 2 Phase 3	Terminated(Sirolimus usage dis... 展开 >>continued since black box warning) 收起 <<	-	-
NCT00193635	Congenital Urological Abnormal... 展开 >>ities 收起 <<	Phase 1	Completed	-	United States, New Jersey ... 展开 >> Robert Wood Johnson Medical center New Brunswick, New Jersey, United States, 08903-0019 United States, New York Schneider Children's Hospital New Hyde Park, New York, United States, 11040 Cornell Weill Medical Center New York, New York, United States, 10021-4873 收起 <<
NCT01709136	-		Terminated(Sirolimus usage dis... 展开 >>continued since black box warning) 收起 <<	-	-
NCT00275639	Liver Transplant Recipients	Phase 4	Completed	-	United States, Minnesota ... 展开 >> Mayo Clinic Rochester, Minnesota, United States, 55905 收起 <<
NCT01158742	-		Completed	-	United States, Alabama ... 展开 >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 Mayo Clinic Rochester, Minnesota, United States, 55905 收起 <<
NCT00255398	-		Completed	-	United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 <<
NCT00472082	-		Terminated(This study was term... 展开 >>inated at the request of the drug manufacturer.) 收起 <<	-	-
NCT00846729	-		Completed	-	United States, California ... 展开 >> Stanford University School of Medicine Stanford, California, United States, 94305 收起 <<
NCT01895114	-		Unknown	December 2015	United States, Texas ... 展开 >> Baylor All Saint's Medical Center in Fort Worth Recruiting Fort Worth, Texas, United States, 76104 Contact: Erin Fassett, RN,MSN,MBA 214-820-7755 Erin.Fassett@baylorhealthe.du Contact: Michelle Acker, RN 214-820-6624 Michelle.Acker@baylorhealth.edu 收起 <<
NCT00286156	Polycystic Kidney Diseases	Phase 1 Phase 2	Completed	-	United States, Ohio ... 展开 >> The Cleveland Clinic- main campus Cleveland, Ohio, United States, 44195 收起 <<
NCT00286156	-		Completed	-	-
NCT03190070	Kidney Diseases	Not Applicable	Recruiting	June 1, 2019	United States, Massachusetts ... 展开 >> Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 收起 <<
NCT00026715	-		Completed	-	United States, Maryland ... 展开 >> National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Bethesda, Maryland, United States, 20892 收起 <<
NCT00472082	Kidney Transplantation ... 展开 >> Chronic Kidney Failure 收起 <<	Phase 1 Phase 2	Terminated(This study was term... 展开 >>inated at the request of the drug manufacturer.) 收起 <<	-	United States, Georgia ... 展开 >> Emory University Atlanta, Georgia, United States, 30322 收起 <<
NCT00275535	Kidney Diseases	Phase 4	Completed	-	United States, Minnesota ... 展开 >> Mayo Clinic Rochester, Minnesota, United States, 55905 收起 <<
NCT01180101	Chronic Kidney Disease ... 展开 >> Obesity 收起 <<	Phase 2 Phase 3	Completed	-	United States, Ohio ... 展开 >> Cleveland Clinic Cleveland, Ohio, United States, 44195 收起 <<
NCT01755858	Renal Artery Obstruction ... 展开 >> Hypertension, Renovascular Ischemia Reperfusion Injury 收起 <<	Phase 1 Phase 2	Terminated	-	United States, Minnesota ... 展开 >> Mayo Clinic Rochester, Minnesota, United States, 55905 收起 <<

Iotalamic acid/碘他拉酸 {[allProObj[0].p_purity_real_show]}

Iotalamic acid/碘他拉酸纯度/质量文件产品仅供科研

全球学术期刊中引用的产品

Iotalamic acid/碘他拉酸质控信息

Iotalamic acid/碘他拉酸生物活性

Iotalamic acid/碘他拉酸临床研究

Iotalamic acid/碘他拉酸参考文献

Iotalamic acid/碘他拉酸实验方案

Iotalamic acid/碘他拉酸技术信息

最近浏览的产品

大规格询价

摩尔计算器

靶点

总药量计算器

工作液计算器

细胞研究

临床研究

确认信息

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

Iotalamic acid/碘他拉酸 {[allProObj[0].p_purity_real_show]}

Iotalamic acid/碘他拉酸 纯度/质量文件 产品仅供科研

全球学术期刊中引用的产品

Iotalamic acid/碘他拉酸 质控信息

Iotalamic acid/碘他拉酸 生物活性

Iotalamic acid/碘他拉酸 临床研究

Iotalamic acid/碘他拉酸 参考文献

Iotalamic acid/碘他拉酸 实验方案

Iotalamic acid/碘他拉酸 技术信息

最近浏览的产品

大规格询价

摩尔计算器

靶点

总药量计算器

工作液计算器

细胞研究

临床研究

确认信息

请登录您的专属账户

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

Iotalamic acid/碘他拉酸纯度/质量文件产品仅供科研

Iotalamic acid/碘他拉酸质控信息

Iotalamic acid/碘他拉酸生物活性

Iotalamic acid/碘他拉酸临床研究

Iotalamic acid/碘他拉酸参考文献

Iotalamic acid/碘他拉酸实验方案

Iotalamic acid/碘他拉酸技术信息